S. Toyooka

S. Toyooka, M. Aoe, H. Date, 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

CT fluoroscopy-guided cutting needle biopsy of focal pure ground-glass opacity lung lesions: diagnostic yield in 83 lesions.

S. Toyooka, S. Kanazawa, Katsuya Kato, 2012, European Journal of Radiology.

DNA Methylation Profiles of Lymphoid and Hematopoietic Malignancies

Yingye Zheng, Ziding Feng, Adi F. Gazdar, 2004, Clinical Cancer Research.

Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA

S. Toyooka, K. Mimori, Y. Yatabe, 2021, Cancer science.

Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer

J. Minna, S. Toyooka, J. Roth, 2003, International journal of cancer.

Percutaneous Radiofrequency Ablation of Lung Cancer Presenting as Ground-Glass Opacity

J. Soh, S. Toyooka, K. Kiura, 2014, CardioVascular and Interventional Radiology.

Epigenetic down-regulation of death-associated protein kinase in lung cancers.

S. Lam, S. Toyooka, M. Tockman, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

DNA methylation of multiple genes and clinicopathological relationship of non-small cell lung cancers.

S. Toyooka, M. Aoe, M. Yano, 2004, Oncology reports.

Right but not left ventricular function recovers early after living-donor lobar lung transplantation in patients with pulmonary arterial hypertension.

S. Toyooka, H. Date, S. Fuke, 2009, The Journal of thoracic and cardiovascular surgery.

Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.

S. Toyooka, A. Gazdar, F. Sato, 2002, Cancer research.

Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients

J. Soh, S. Toyooka, S. Kanazawa, 2017, Japanese Journal of Radiology.

Radiofrequency ablation of lung metastases from adenoid cystic carcinoma of the head and neck: retrospective evaluation of nine patients.

S. Toyooka, S. Kanazawa, H. Gobara, 2015, Journal of vascular and interventional radiology : JVIR.

Phrenic nerve injury after radiofrequency ablation of lung tumors: retrospective evaluation of the incidence and risk factors.

S. Toyooka, S. Kanazawa, H. Gobara, 2012, Journal of vascular and interventional radiology : JVIR.

Brachial nerve injury caused by percutaneous radiofrequency ablation of apical lung cancer: a report of four cases.

S. Toyooka, S. Kanazawa, Y. Sano, 2010, Journal of vascular and interventional radiology : JVIR.

Feasibility of percutaneous radiofrequency ablation for intrathoracic malignancies

S. Toyooka, M. Aoe, H. Date, 2007, Cancer.

The proliferative effects of asbestos-exposed peripheral blood mononuclear cells on mesothelial cells

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2016, Oncology letters.

Safety of salvage lung resection after immunotherapy for unresectable non-small cell lung cancer

S. Toyooka, Y. Sano, M. Okazaki, 2022, General Thoracic and Cardiovascular Surgery.

Hypertension After Failure of Epoprostenol Therapy Living-Donor Lobar Lung Transplantation for Pulmonary Arterial

S. Toyooka, M. Aoe, A. Ogawa, 2011 .

Living-donor lobar lung transplantation for pulmonary arterial hypertension after failure of epoprostenol therapy.

S. Toyooka, M. Aoe, H. Date, 2007, Journal of the American College of Cardiology.

Evaluation of Therapeutic Target Gene Expression Based on Residual Cancer Burden Classification After Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer.

Hirokuni Ikeda, N. Taira, S. Toyooka, 2020, Clinical breast cancer.

A case of delayed massive hemothorax caused by the rupture of a pulmonary artery pseudoaneurysm after radiofrequency ablation of lung tumors.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Japanese journal of clinical oncology.

Multiplex gene‐panel testing for lung cancer patients

S. Toyooka, S. Ikeda, Y. Yatabe, 2020, Pathology international.

Percutaneous radiofrequency ablation of clinical stage I non-small cell lung cancer.

S. Toyooka, S. Kanazawa, H. Gobara, 2011, The Journal of thoracic and cardiovascular surgery.

The aberrant promoter methylation of BMP3b and BMP6 in malignant pleural mesotheliomas.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2008, Oncology reports.

Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study

S. Toyooka, K. Kiura, M. Kuroda, 2021, Radiation Oncology.

Summary of the Japanese Respiratory Society statement for the treatment of lung cancer with comorbid interstitial pneumonia.

Hiromasa Yamamoto, S. Toyooka, A. Gemma, 2019, Respiratory investigation.

Antitumor Effects of Pan-RAF Inhibitor LY3009120 Against Lung Cancer Cells Harboring Oncogenic BRAF Mutation

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2020, AntiCancer Research.

The Effect of Gefitinib on B-RAF Mutant Non-small Cell Lung Cancer and Transfectants

J. Soh, S. Toyooka, T. Mitsudomi, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Non-BAC Component but not Epidermal Growth Factor Receptor Gene Mutation is Associated with Poor Outcomes in Small Adenocarcinoma of the Lung

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lung transplant candidates with idiopathic pulmonary fibrosis and long-term pirfenidone therapy: Treatment feasibility influences waitlist survival.

S. Toyooka, K. Kiura, S. Sugimoto, 2019, Respiratory investigation.

Is Surgery after Chemoradiotherapy Feasible in Lung Cancer Patients with Superior Vena Cava Invasion?

J. Soh, S. Toyooka, K. Kiura, 2018, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.

J. Soh, S. Toyooka, S. Miyoshi, 2015, Interactive cardiovascular and thoracic surgery.

A case of solitary bronchial papilloma mimicking hilar lung cancer on positron emission tomography

S. Toyooka, Y. Sano, T. Oto, 2009 .

Current status of postoperative follow-up for lung cancer in Japan: questionnaire survey by the Setouchi Lung Cancer Study Group—A0901

S. Toyooka, H. Date, H. Tada, 2012, General Thoracic and Cardiovascular Surgery.

Clinical outcomes of short hook wire and suture marking system in thoracoscopic resection for pulmonary nodules.

S. Toyooka, H. Date, S. Kanazawa, 2009, European Journal of Cardio-Thoracic Surgery.

Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells

J. Minna, S. Toyooka, A. Gazdar, 2002, Oncogene.

Model of lung cancer surgery risk derived from a Japanese nationwide web-based database of 78 594 patients during 2014–2015†

H. Miyata, S. Toyooka, M. Okada, 2017, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Long-term survival following percutaneous radiofrequency ablation of colorectal lung metastases.

S. Toyooka, S. Kanazawa, T. Nagasaka, 2015, Journal of vascular and interventional radiology : JVIR.

Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension

S. Toyooka, M. Sakaguchi, Y. Higashimoto, 2018, PloS one.

Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis.

S. Toyooka, A. Ohtsuka, A. Ogawa, 2013, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Induction chemoradiotherapy using docetaxel and cisplatin with definitive-dose radiation followed by surgery for locally advanced non-small cell lung cancer.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2017, Journal of thoracic disease.

DNA methylation in small lung adenocarcinoma with bronchioloalveolar carcinoma components.

Hiromasa Yamamoto, S. Toyooka, K. Kiura, 2009, Lung Cancer.

The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis

Hiromasa Yamamoto, S. Toyooka, K. Ichimura, 2020, Journal of Molecular Medicine.

Association between Histological Types and Enhancement of Dynamic CT for Primary Lung Cancer.

J. Soh, S. Toyooka, S. Kanazawa, 2020, Acta Medica Okayama.

Advantage of Induction Chemoradiotherapy for Lung Cancer in Securing Cancer-Free Bronchial Margin.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2017, The Annals of thoracic surgery.

Extended sleeve lobectomy after induction chemoradiotherapy for non-small cell lung cancer

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2015, Surgery Today.

DNA Methylation Profiles of Lung Tumors 1

J. Minna, S. Toyooka, L. Girard, 2001 .

Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2019, Oncology letters.

Downregulation of TBXAS1 in an iron-induced malignant mesothelioma model

S. Toyooka, K. Kiura, M. Tabata, 2015, Cancer science.

A New Scoring System for Predicting the Survival of Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score

Hiromasa Yamamoto, S. Toyooka, H. Yamamoto, 2020, Annals of Surgical Oncology.

A Simple Prognostic Benefit Scoring System for Sarcoma Patients with Pulmonary Metastases: Sarcoma Lung Metastasis Score

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2020, Annals of Surgical Oncology.

Long-Term Survival after Radiofrequency Ablation of Lung Oligometastases from Five Types of Primary Lesions: A Retrospective Evaluation.

S. Toyooka, S. Kanazawa, T. Nagasaka, 2016, Journal of vascular and interventional radiology : JVIR.

A Novel Strategy for Treatment of Metastatic Pulmonary Tumors: Radiofrequency Ablation in Conjunction with Surgery

S. Toyooka, H. Date, S. Kanazawa, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Triplet chemotherapy with cisplatin, docetaxel, and irinotecan for patients with recurrent or refractory non-small cell lung cancer.

S. Toyooka, K. Kiura, M. Tabata, 2010, Acta medica Okayama.

Short hookwire placement under imaging guidance before thoracic surgery: A review.

S. Toyooka, S. Kanazawa, H. Gobara, 2018, Diagnostic and interventional imaging.

Simultaneous Multiple Preoperative Localizations of Small Pulmonary Lesions Using a Short Hook Wire and Suture System

S. Toyooka, S. Miyoshi, S. Kanazawa, 2015, CardioVascular and Interventional Radiology.

Transfissural Route Used for Preoperative Localization of Small Pulmonary Lesions with a Short Hook Wire and Suture System

S. Toyooka, S. Miyoshi, S. Kanazawa, 2015, CardioVascular and Interventional Radiology.

Adjuvant chemotherapy for non small-cell lung cancer

S. Toyooka, 2018 .

Distant Bystander Effect of REIC/DKK3 Gene Therapy Through Immune System Stimulation in Thoracic Malignancies.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2017, Anticancer research.

Risk assessments for broncho-pleural fistula and respiratory failure after lung cancer surgery by National Clinical Database Japan

H. Miyata, S. Toyooka, M. Okada, 2018, General Thoracic and Cardiovascular Surgery.

Pulmonary lymphatic involvement in metastatic uterine sarcomas: imaging and pathological appearance

S. Toyooka, S. Kanazawa, H. Yanai, 2021, Radiology case reports.

Application of amplicon-based targeted sequencing with the molecular barcoding system to detect uncommon minor EGFR mutations in patients with treatment-naïve lung adenocarcinoma

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2019, BMC Cancer.

Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small cell lung cancer.

S. Toyooka, T. Mitsudomi, M. Satouchi, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Percutaneous computed tomography‐guided lung biopsy and pleural dissemination

S. Toyooka, H. Date, S. Kanazawa, 2009, Cancer.

Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction.

Hiromasa Yamamoto, S. Toyooka, K. Kiura, 2020, Oncology letters.

Updated overall survival results of WJTOG 3405, a randomized phase III trial comparing gefitinib (G) with cisplatin plus docetaxel (CD) as the first-line treatment for patients with non-small cell lung cancer harboring mutations of the epidermal growth factor receptor (EGFR).

S. Toyooka, Y. Yatabe, T. Mitsudomi, 2012 .

Establishment and molecular characterization of cell lines from Japanese patients with malignant pleural mesothelioma.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2016, Oncology letters.

Clinical impacts of EGFR mutation status: analysis of 5,780 surgically resected lung cancer cases.

E. Miyaoka, S. Toyooka, H. Asamura, 2020, The Annals of thoracic surgery.

Detection of codon 61 point mutations of the K-ras gene in lung and colorectal cancers by enriched PCR.

J. Soh, S. Toyooka, M. Yano, 2003, Oncology Report.

Risk Factors for Recurrence and Unfavorable Prognosis in Patients with Stage I Non-small Cell Lung Cancer and a Tumor Diameter of 20 mm or Less

J. Soh, S. Toyooka, M. Aoe, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Sequential Molecular Changes during Multistage Pathogenesis of Small Peripheral Adenocarcinomas of the Lung

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2014, Surgery Today.

PD-160 The relationship between epidermal growth factor receptor (EGFR) mutations and clinicopathologic features in non-small cell lung cancers

S. Toyooka, A. Gazdar, K. Kiura, 2005 .

Detection of EGFR Gene Mutations Using the Wash Fluid of CT-Guided Biopsy Needle in NSCLC Patients

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

DNA methylation status of REIC/Dkk-3 gene in human malignancies

N. Taira, J. Soh, S. Toyooka, 2012, Journal of Cancer Research and Clinical Oncology.

METex14 Skipping Testing Guidance for Lung Cancer Patients: The Guidance from the Biomarker Committee, the Japan Lung Cancer Society

S. Toyooka, S. Ikeda, Y. Yatabe, 2021, Haigan.

Detection of EGFR Gene Mutation in Lung Cancer by Mutant-Enriched Polymerase Chain Reaction Assay

S. Toyooka, Masaki Tokumo, K. Kiura, 2006, Clinical Cancer Research.

DNA copy number gains in malignant pleural mesothelioma.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2015, Oncology letters.

One-step nucleic acid amplification for intraoperative diagnosis of lymph node metastasis in lung cancer patients: a single-center prospective study

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2022, Scientific reports.

Influence of Radiofrequency Ablation of Lung Cancer on Pulmonary Function

S. Toyooka, K. Kiura, T. Tsuda, 2012, CardioVascular and Interventional Radiology.

Trastuzumab Emtansine in HER2+ Recurrent Metastatic Non–Small‐Cell Lung Cancer: Study Protocol

S. Toyooka, K. Kiura, M. Takata, 2017, Clinical lung cancer.

A case of pancreatic adenocarcinoma with novel K-ras mutation and long term survival

J. Soh, S. Toyooka, K. Tsukuda, 2002, American Journal of Gastroenterology.

A case of pancreatic adenocarcinoma with novel K-ras mutation and long term survival.

J. Soh, S. Toyooka, K. Tsukuda, 2002 .

Elacridar, a third-generation ABCB1 inhibitor, overcomes resistance to docetaxel in non-small cell lung cancer.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2017, Oncology letters.

YES1 activation induces acquired resistance to neratinib in HER2‐amplified breast and lung cancers

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2019, Cancer Science.

Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2017, PloS one.

Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour

S. Toyooka, A. Gazdar, M. Toyota, 2005, British Journal of Cancer.

Aberrant promoter methylation of human DAB2 interactive protein (hDAB2IP) gene in lung cancers

S. Toyooka, A. Gazdar, M. Aoe, 2005, International journal of cancer.

Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)

H. Aburatani, H. Ueno, S. Toyooka, 2020, International Journal of Clinical Oncology.

Technique for creation of artificial pneumothorax for pain relief during radiofrequency ablation of peripheral lung tumors: report of seven cases.

S. Toyooka, S. Kanazawa, H. Gobara, 2011, Journal of vascular and interventional radiology : JVIR.

Less Maintenance Immunosuppression in Lung Transplantation Following Hematopoietic Stem Cell Transplantation From the Same Living Donor

S. Toyooka, S. Miyoshi, H. Date, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Aberrant promoter methylation of insulin‐like growth factor binding protein‐3 gene in human cancers

S. Toyooka, H. Doihara, K. Tomii, 2007, International journal of cancer.

Fibrosis or Necrosis in Resected Lymph Node Indicate Metastasis Before Chemoradiotherapy in Lung Cancer Patients

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2020, AntiCancer Research.

Pulmonary aspergillosis as a late complication after surgery for locally advanced non-small cell lung cancer treated with induction chemoradiotherapy

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2020, Surgery Today.

Aberrant methylation and simian virus 40 tag sequences in malignant mesothelioma.

J. Minna, A. Gazdar, S. Toyooka, 2001, Cancer research.

Somatic mutations of the HER2 kinase domain in lung adenocarcinomas.

J. Minna, S. Toyooka, I. Wistuba, 2005, Cancer research.

Current Trial Report Trastuzumab Emtansine in HER2þ Recurrent Metastatic NoneSmall-Cell Lung Cancer: Study Protocol

S. Toyooka, K. Kiura, M. Takata, 2017 .

Circulating anti-human leukocyte antigen IgM antibodies as a potential early predictor of allograft rejection and a negative clinical outcome after lung transplantation

S. Toyooka, S. Sugimoto, K. Miyoshi, 2021, Surgery Today.

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2018, Oncogenesis.

Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments

Hirokuni Ikeda, N. Taira, Hiromasa Yamamoto, 2020, Breast Cancer Research and Treatment.

Tumour size determines both recurrence-free survival and disease-specific survival after surgical treatment for thymoma.

E. Miyaoka, S. Toyooka, M. Tsuboi, 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Long-term spontaneous remission with active surveillance in IgG4-related pleuritis: A case report and literature review

J. Soh, S. Toyooka, K. Kiura, 2019, Respiratory medicine case reports.

Aberrant promoter methylation in pleural fluid DNA for diagnosis of malignant pleural effusion

S. Toyooka, K. Matsuo, H. Ueoka, 2007, International journal of cancer.

The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2013, Lung cancer.

Advances in the molecular biology of malignant mesothelioma.

S. Toyooka, H. Date, T. Kishimoto, 2008, Acta medica Okayama.

Gene therapy using REIC/Dkk-3-encoding adenoviral vector for the treatment of malignant pleural mesothelioma

S. Toyooka, 2015 .

Prolonged warm ischemia exacerbated acute rejection after lung transplantation from donation after cardiac death in a mouse

S. Toyooka, A. Matsukawa, S. Sugimoto, 2019, General Thoracic and Cardiovascular Surgery.

Advances in Brief Aberrant Promoter Methylation Profile of Bladder Cancer and Its Relationship to Clinicopathological Features 1

J. Minna, S. Toyooka, A. Gazdar, 2001 .

Elevation of antidonor immunoglobulin M levels precedes acute lung transplant rejection.

S. Toyooka, S. Miyoshi, Y. Sano, 2011, The Annals of thoracic surgery.

Predictive value of immune genomic signatures from breast cancer cohorts containing data for both response to neoadjuvant chemotherapy and prognosis after surgery

N. Taira, S. Toyooka, T. Shien, 2021, Breast Cancer.

Bronchiolitis obliterans organizing pneumonia after radiofrequency ablation of lung cancer: report of three cases.

S. Toyooka, S. Kanazawa, Katsuya Kato, 2012, Journal of vascular and interventional radiology : JVIR.

Embolization using hydrogel-coated coils for pulmonary arteriovenous malformations.

S. Toyooka, S. Kanazawa, K. Baba, 2019, Diagnostic and interventional imaging.

Primary thymic adenocarcinoma with production of carbohydrate antigen 19-9 and carcinoembryonic antigen.

S. Toyooka, K. Satoh, T. Misao, 2004, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

Peculiar mechanisms of graft recovery through anti-inflammatory responses after rat lung transplantation from donation after cardiac death.

S. Toyooka, S. Miyoshi, Y. Sano, 2012, Transplant immunology.

Low risk donor lungs optimize post-lung transplant outcome for high 1 lung-allocation-score patients 2

S. Toyooka, K. Miyoshi, T. Oto, 2018 .

Current status and potential of living-donor lobar lung transplantation.

S. Toyooka, M. Aoe, H. Date, 2008, Frontiers in Bioscience.

Preoperative short hookwire placement for small pulmonary lesions: evaluation of technical success and risk factors for initial placement failure

S. Toyooka, S. Kanazawa, Takashi Tanaka, 2018, European Radiology.

Suppression of inflammatory cytokines during ex vivo lung perfusion with an adsorbent membrane.

S. Toyooka, S. Miyoshi, Y. Sano, 2010, The Annals of thoracic surgery.

Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan

S. Toyooka, A. Gazdar, T. Murakami, 2006, Cancer science.

Identification of targetable kinases in idiopathic pulmonary fibrosis

Hiromasa Yamamoto, S. Toyooka, K. Kiura, 2021, Respiratory Research.

Living-Donor Lobar Lung Transplantation for Pulmonary Complications After Hematopoietic Stem Cell Transplantation

S. Toyooka, H. Date, Y. Sano, 2008, Transplantation.

Warm retrograde perfusion can remove more fat from lung grafts with fat embolism in a porcine model

S. Toyooka, S. Sugimoto, T. Ohki, 2019, General Thoracic and Cardiovascular Surgery.

Conclusion: Warm retrograde perfusion can remove more fat from lung grafts with fat embolism

S. Toyooka, S. Sugimoto, T. Ohki, 2019 .

Airway bacteria of the recipient but not the donor are relevant to post-lung transplant pneumonia

S. Toyooka, S. Sugimoto, K. Miyoshi, 2019, General Thoracic and Cardiovascular Surgery.

Lung perfusion scintigraphy to detect chronic lung allograft dysfunction after living-donor lobar lung transplantation

S. Toyooka, M. Okazaki, S. Sugimoto, 2020, Scientific Reports.

Impact of chronic lung allograft dysfunction, especially restrictive allograft syndrome, on the survival after living-donor lobar lung transplantation compared with cadaveric lung transplantation in adults: a single-center experience

S. Toyooka, M. Okazaki, S. Sugimoto, 2019, Surgery Today.

A single-nucleotide polymorphism in a gene modulating glucocorticoid sensitivity is associated with the decline in total lung capacity after lung transplantation

N. Taira, S. Toyooka, S. Sugimoto, 2018, Surgery Today.

Single nucleotide polymorphism in a gene modulating glucocorticoid sensitivity 2 is associated with decline in total lung capacity after lung transplantation

N. Taira, S. Toyooka, S. Sugimoto, 2018 .

Long-term follow-up of living-donor single lobe transplantation for idiopathic pulmonary arterial hypertension in a child.

S. Toyooka, H. Date, Y. Sano, 2008, The Journal of thoracic and cardiovascular surgery.

Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer.

J. Soh, S. Toyooka, S. Miyoshi, 2014, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Case report Postoperative perforation in the bronchus intermedius membrane after a primary lung cancer resection

S. Toyooka, H. Date, Y. Sano, 2008 .

SOCS3 overexpression in T cells ameliorates chronic airway obstruction in a murine heterotopic tracheal transplantation model

S. Toyooka, S. Miyoshi, A. Matsukawa, 2019, Surgery Today.

Paediatric lung transplantation: the impact of age on the survival

Hiromasa Yamamoto, S. Toyooka, K. Suzawa, 2022, Surgery Today.

Native lung-sparing lobar transplantation for pulmonary emphysema.

S. Toyooka, M. Aoe, H. Date, 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

A case of ileal perforation of malignant lymphoma occurring after lung transplantation

S. Toyooka, T. Nogami, K. Tsukuda, 2011 .

Frequent p16 inactivation by homozygous deletion or methylation is associated with a poor prognosis in Japanese patients with pleural mesothelioma.

Hiromasa Yamamoto, J. Soh, S. Toyooka, 2008, Lung cancer.

The impact of COVID-19 on thoracic surgical procedures in Japan: Analysis of data from the National Clinical Database

S. Toyooka, I. Yoshino, Y. Okada, 2022, Lung Cancer.

Development of an annually updated Japanese national clinical database for chest surgery in 2014

H. Miyata, S. Toyooka, Koichi Yoshida, 2016, General Thoracic and Cardiovascular Surgery.

Sirolimus amelioration of clinical symptoms of recurrent lymphangioleiomyomatosis after living-donor lobar lung transplantation.

S. Toyooka, M. Aoe, H. Date, 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

"Hybrid Lung Transplantation" Combining Living Donor and Cadaveric Lung Transplants: Report of 2 Cases.

S. Toyooka, S. Sugimoto, K. Miyoshi, 2021, Transplantation proceedings.

Covalent N-arylation by the pollutant 1,2-naphthoquinone activates the EGF receptor

S. Toyooka, K. Shien, T. Uehara, 2021, The Journal of biological chemistry.

Inherited lung cancer syndromes targeting never smokers.

Hiromasa Yamamoto, S. Toyooka, Y. Yatabe, 2018, Translational Lung Cancer Research.

Emphysematous changes and lower levels of plasma irisin are associated with bronchiolitis obliterans syndrome after bilateral living-donor lobar lung transplantation

Hiromasa Yamamoto, S. Toyooka, K. Suzawa, 2021, Surgery Today.

Takotsubo cardiomyopathy associated with pulmonary resections after induction chemoradiotherapy for non-small cell lung cancer

J. Soh, S. Toyooka, S. Miyoshi, 2012, General Thoracic and Cardiovascular Surgery.

Fever after lung radiofrequency ablation: Prospective evaluation of its incidence and associated factors.

J. Soh, S. Toyooka, K. Kiura, 2015, European journal of radiology.

The relationship between NY-ESO-1 mRNA expression and clinicopathological features in non-small cell lung cancer.

S. Toyooka, M. Aoe, K. Tsukuda, 2004, Oncology reports.

Feasibility of Pulmonary Resection for Lung Cancer in Patients With Coronary Artery Disease or Atrial Fibrillation.

Kenji Suzuki, S. Toyooka, M. Sonobe, 2017, The Annals of thoracic surgery.

Survival and prognostic factors in patients undergoing pulmonary metastasectomy for lung metastases from retroperitoneal sarcoma

Hiromasa Yamamoto, S. Toyooka, K. Shien, 2022, World Journal of Surgical Oncology.

YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development

N. Taira, S. Toyooka, T. Shien, 2021, International journal of molecular sciences.

Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non‐small cell lung cancer: Analysis of dose‐volume parameters

S. Toyooka, K. Kiura, M. Kuroda, 2020, Cancer medicine.

Methylation Profiling of Lung Cancer: A Decade of Progress

S. Toyooka, A. Gazdar, 2011, Molecular Cancer Therapeutics.

Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines.

S. Toyooka, A. Maitra, A. Gazdar, 2002, Cancer research.

A Phase II Study of Trastuzumab Emtansine in HER2‐Positive Non–Small Cell Lung Cancer

S. Toyooka, K. Kiura, K. Hotta, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Impact of the preoperative body mass index on the postoperative outcomes in patients with completely resected non-small cell lung cancer: A retrospective analysis of 16,503 cases in a Japanese Lung Cancer Registry Study.

E. Miyaoka, S. Toyooka, H. Asamura, 2020, Lung cancer.

Current status of inhaled nitric oxide therapy for lung transplantation in Japan: a nationwide survey

S. Toyooka, H. Date, T. Nagayasu, 2021, General Thoracic and Cardiovascular Surgery.

ASO Author Reflections: Impact of the Postoperative Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small Cell Lung Cancer Treated with Induction Chemoradiotherapy Followed by Surgery

Hiromasa Yamamoto, S. Toyooka, S. Tsudaka, 2021, Annals of Surgical Oncology.

Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification

J. Minna, S. Toyooka, A. Gazdar, 2002, Oncogene.

Lung transplantation for idiopathic multicentric Castleman disease: potential efficacy and tolerability of a humanized anti-interleukin-6 receptor monoclonal antibody

Hiromasa Yamamoto, S. Toyooka, K. Shien, 2021, Surgical Case Reports.

The impact of prolonged cold preservation on the graft function and gene expression levels in an experimental lung transplantation model

S. Toyooka, S. Miyoshi, Y. Sano, 2012, Surgery Today.

Use of a vessel sealing system versus conventional electrocautery for lung parenchymal resection: a comparison of the clinicopathological outcomes in porcine lungs

J. Soh, S. Toyooka, S. Miyoshi, 2014, Surgery Today.

SPRED2 deficiency may lead to lung ischemia–reperfusion injury via ERK1/2 signaling pathway activation

S. Toyooka, S. Miyoshi, A. Matsukawa, 2018, Surgery Today.

Functional Blockage of S100A8/A9 Ameliorates Ischemia–Reperfusion Injury in the Lung

Hiromasa Yamamoto, S. Toyooka, M. Sakaguchi, 2022, Bioengineering.

Ileal perforation induced by acute radiation injury under gefitinib treatment

S. Toyooka, S. Miyoshi, K. Tsukuda, 2011, International Journal of Clinical Oncology.

Dry small pleural dissemination of adenocarcinoma of the lung preoperatively detected by PET/CT: a report of two cases.

S. Toyooka, M. Aoe, H. Date, 2008, Acta medica Okayama.

Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast

Hiromasa Yamamoto, S. Toyooka, T. Shien, 2022, Cancer science.

Lymphangioleiomyomatosis Sirolimus Ameliorated Post Lung Transplant Chylothorax in

S. Toyooka, Y. Sano, T. Ohara, 2013 .

Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis.

S. Toyooka, H. Date, Y. Sano, 2008, The Annals of thoracic surgery.

Clinical features and prognostic impact of coexisting autoimmune disease other than myasthenia gravis in resected thymomas: analysis of a Japanese multi-institutional retrospective database.

S. Toyooka, M. Tsuboi, H. Asamura, 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Models for studying DNA methylation in human cancer: a review of current status

S. Toyooka, N. Shimizu, 2004 .

Feasibility of lung transplantation from donors mechanically ventilated for prolonged 3 periods 4 5

S. Toyooka, S. Sugimoto, T. Oto, 2020 .

Feasibility of lung transplantation from donors mechanically ventilated for prolonged periods

S. Toyooka, S. Sugimoto, T. Oto, 2018, Surgery today (Print).

Hazard Function Analysis of Recurrence in Patients with Curatively Resected Lung Cancer: Results from the Japanese Lung Cancer Registry in 2010

E. Miyaoka, S. Toyooka, H. Asamura, 2022, Cancers.

The heterodimer S100A8/A9 is a potent therapeutic target for idiopathic pulmonary fibrosis

S. Toyooka, K. Ichimura, M. Sakaguchi, 2020, Journal of Molecular Medicine.

Percutaneous radiofrequency ablation for pulmonary metastases from esophageal cancer: retrospective evaluation of 21 patients.

S. Toyooka, S. Kanazawa, T. Fujiwara, 2014, Journal of vascular and interventional radiology : JVIR.

Low-risk donor lungs optimize the post-lung transplant outcome for high lung allocation score patients

S. Toyooka, S. Sugimoto, K. Miyoshi, 2018, Surgery Today.

Histidine-Rich Glycoprotein Suppresses the S100A8/A9-Mediated Organotropic Metastasis of Melanoma Cells

S. Toyooka, M. Sakaguchi, K. Suzawa, 2022, International journal of molecular sciences.

Right single lung transplantation using an inverted left donor lung: interposition of pericardial conduit for pulmonary venous anastomosis - a case report

S. Toyooka, S. Sugimoto, K. Miyoshi, 2020, BMC Pulmonary Medicine.

Inhibiting S100A8/A9 attenuates airway obstruction in a mouse model of heterotopic tracheal transplantation.

S. Toyooka, M. Sakaguchi, A. Matsukawa, 2022, Biochemical and biophysical research communications.

Presence of Simian Virus 40 DNA Sequences in Human Lymphoid and Hematopoietic Malignancies and Their Relationship to Aberrant Promoter Methylation of Multiple Genes

R. Collins, S. Toyooka, A. Gazdar, 2004, Cancer Research.

Early-stage antibody kinetics after the third dose of BNT162b2 mRNA COVID-19 vaccination measured by a point-of-care fingertip whole blood testing

S. Toyooka, Koichiro Yamamoto, T. Yorifuji, 2022, Scientific Reports.

Intrathoracic irrigation with arbekacin for methicillin-resistant Staphylococcus aureus empyema following lung resection.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Interactive cardiovascular and thoracic surgery.

Newly developed anti‐S100A8/A9 monoclonal antibody efficiently prevents lung tropic cancer metastasis

J. Soh, S. Toyooka, Hiroki Sato, 2018, International journal of cancer.

exSSSRs (extracellular S100 soil sensor receptors)‐Fc fusion proteins work as prominent decoys to S100A8/A9‐induced lung tropic cancer metastasis

J. Soh, S. Toyooka, Hiroki Sato, 2018, International journal of cancer.

β-1,3-Galactosyl-O-Glycosyl-Glycoprotein β-1,6-N-Acetylglucosaminyltransferase 3 Increases MCAM Stability, Which Enhances S100A8/A9-Mediated Cancer Motility.

S. Toyooka, M. Sakaguchi, S. Tomida, 2018, Oncology research.

Hsp 90 inhibitor NVP-AUY 922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors

J. Soh, S. Toyooka, S. Miyoshi, 2015 .

The impact and role of EGFR gene mutation on non-small cell lung cancer

J. Soh, S. Toyooka, H. Shigematsu, 2006, Cancer Chemotherapy and Pharmacology.

Combined inhibition of MEK and PI3K pathways overcomes acquired resistance to EGFR‐TKIs in non‐small cell lung cancer

Hirokuni Ikeda, J. Soh, S. Toyooka, 2018, Cancer science.

Epigenetic Regulation of a Novel Tumor Suppressor Gene (hDAB2IP) in Prostate Cancer Cell Lines* 210

S. Toyooka, A. Gazdar, J. Hsieh, 2003, The Journal of Biological Chemistry.

Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.

J. Minna, S. Toyooka, A. Gazdar, 2001, Cancer research.

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.

J. Minna, A. Gazdar, S. Toyooka, 2001, Journal of the National Cancer Institute.

Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.

J. Minna, A. Gazdar, S. Toyooka, 2001, Cancer research.

EGFR Mutation Testing Practices within the Asia Pacific Region

S. Toyooka, Y. Yatabe, Keunchil Park, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

New treatment strategy for patients with EGFR-mutant lung cancer

S. Toyooka, K. Kiura, M. Tanimoto, 2013 .

Molecular oncology of lung cancer

J. Soh, S. Toyooka, S. Miyoshi, 2011, General thoracic and cardiovascular surgery.

Molecular biology of lung cancer

J. Soh, S. Toyooka, S. Miyoshi, 2010 .

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

Kenichi Harada, Charles F Timmons, John D Minna, 2002, Oncogene.

Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells.

W. Lam, J. Soh, S. Toyooka, 2013, Cancer research.

Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells

Calum MacAulay, John D. Minna, David S. Shames, 2009, PloS one.

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY).

S. Toyooka, K. Kiura, M. Takata, 2019, Chest.

Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma.

S. Toyooka, A. Gazdar, B. Leggett, 2002, Cancer research.

Advances in Brief Aberrant Methylation of the HPP 1 Gene in Ulcerative Colitis-associated Colorectal Carcinoma 1

S. Toyooka, A. Gazdar, B. Leggett, 2002 .

The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer

J. Minna, S. Toyooka, M. Peyton, 2005, Oncogene.

Establishment and validation of real-time polymerase chain reaction method for CDH1 promoter methylation.

J. Minna, S. Toyooka, A. Maitra, 2002, The American journal of pathology.

Therapeutic Potential of Afatinib for Cancers with ERBB2 (HER2) Transmembrane Domain Mutations G660D and V659E.

Shigemi Matsumoto, Takashi Ninomiya, Shuta Tomida, 2018, The oncologist.

Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma

J. Soh, S. Toyooka, S. Miyoshi, 2011, Clinical Cancer Research.

Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types

S. Toyooka, A. Gazdar, H. Pass, 2004, International journal of cancer.

Advances in Brief Aberrant Methylation and Simian Virus 40 Tag Sequences in Malignant Mesothelioma 1

J. Minna, S. Toyooka, A. Gazdar, 2001 .

Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features

J. Soh, S. Toyooka, S. Miyoshi, 2017, Scientific Reports.

MAPK Pathway Alterations Correlate with Poor Survival and Drive Resistance to Therapy in Patients with Lung Cancers Driven by ROS1 Fusions

M. Ladanyi, A. Drilon, M. Kris, 2020, Clinical Cancer Research.

Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.

J. Soh, S. Toyooka, S. Miyoshi, 2017, Oncology reports.

Genetic predictors of MEK dependence in non-small cell lung cancer.

William Pao, Barry S Taylor, Neal Rosen, 2008, Cancer research.

Calcineurin inhibitor-related cholestasis complicating lung transplantation.

S. Toyooka, S. Miyoshi, M. Egi, 2010, The Annals of thoracic surgery.

Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma

S. Toyooka, A. Ohtsuka, N. Mizuno, 2020, BMC Cancer.

DNA methylation profiles of lung tumors.

J. Minna, S. Toyooka, L. Girard, 2001, Molecular cancer therapeutics.

Aberrant methylation of p21 gene in lung cancer and malignant pleural mesothelioma.

Hiroaki Asano, Kazunori Tsukuda, J. Soh, 2011, Acta medica Okayama.

Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers

S. Toyooka, Y. Naomoto, S. Tanabe, 2010, Journal of Cancer Research and Clinical Oncology.

The allelic distribution of a single nucleotide polymorphism in the PDCD5 gene locus of Japanese non-small cell lung cancer patients.

J. Soh, S. Toyooka, K. Matsuo, 2008, Molecular medicine reports.

Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells

J. Soh, S. Toyooka, Hiroki Sato, 2018, Molecular Cancer Research.

Oncogenic potential of human pluripotent stem cell‐derived lung organoids with HER2 overexpression

S. Toyooka, M. Sakaguchi, S. Tomida, 2021, International journal of cancer.

Mutational and epigenetic evidence for independent pathways for lung adenocarcinomas arising in smokers and never smokers.

S. Toyooka, A. Gazdar, K. Matsuo, 2006, Cancer research.

Promoter Hypermethylation Profile of Ovarian Epithelial Neoplasms

J. Minna, S. Toyooka, A. Gazdar, 2005, Clinical Cancer Research.

Embigin Promotes Prostate Cancer Progression by S100A4-Dependent and-Independent Mechanisms

S. Toyooka, Hiroki Sato, M. Sakaguchi, 2018, Cancers.

Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations

J. Soh, S. Toyooka, W. Travis, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Downregulation of microRNA-34 induces cell proliferation and invasion of human mesothelial cells.

J. Soh, S. Toyooka, S. Miyoshi, 2013, Oncology reports.

TAE226, a Bis-Anilino Pyrimidine Compound, Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells

J. Soh, S. Toyooka, S. Miyoshi, 2015, PloS one.

Comprehensive analysis of EGFR signaling pathways in Japanese patients with non-small cell lung cancer.

J. Soh, S. Toyooka, Masaki Tokumo, 2009, Lung cancer.

DNA methylation in lung cancer.

S. Toyooka, A. Gazdar, K. Matsuo, 2008, The New England journal of medicine.

Dose effect of smoking on aberrant methylation in non‐small cell lung cancers

J. Minna, S. Toyooka, A. Gazdar, 2004, International journal of cancer.

Aberrant Promoter Methylation in Human DAB2 Interactive Protein (hDAB2IP) Gene in Breast Cancer

S. Toyooka, H. Doihara, A. Gazdar, 2004, Clinical Cancer Research.

Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection

S. Toyooka, A. Gazdar, H. Pass, 2005, Oncogene.

Brief Report: Rapid Acquisition of Alectinib Resistance in ALK-positive Lung Cancer with High Tumor Mutation Burden.

S. Toyooka, K. Kiura, M. Tabata, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Droplet digital PCR as a novel system for the detection of microRNA‑34b/c methylation in circulating DNA in malignant pleural mesothelioma.

J. Soh, S. Toyooka, Hiroki Sato, 2019, International journal of oncology.

The TP53 gene, tobacco exposure, and lung cancer

Toshihide Tsuda, S. Toyooka, A. Gazdar, 2003, Human mutation.

Double mutation and gene copy number of EGFR in gefitinib refractory non-small-cell lung cancer.

S. Toyooka, Masaki Tokumo, K. Kiura, 2006, Lung cancer.

Diagnostic Value of Dual-time-point F-18 FDG PET/CT and Chest CT for the Prediction of Thymic Epithelial Neoplasms.

J. Soh, S. Toyooka, S. Miyoshi, 2017, Acta medica Okayama.

Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Locally Advanced Non-small-cell Lung Cancer Treated with Trimodality Therapy

S. Toyooka, K. Kiura, K. Shien, 2021, Annals of Surgical Oncology.

The prognostic impact of sarcopenia on elderly patients undergoing pulmonary resection for non-small cell lung cancer

S. Toyooka, K. Suzawa, M. Okazaki, 2021, Surgery Today.

Prognostic nutrition index affects the prognosis of patients undergoing trimodality therapy for locally advanced non-small cell lung cancer

J. Soh, S. Toyooka, K. Kiura, 2020, Surgery Today.

Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010

E. Miyaoka, S. Toyooka, H. Asamura, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1

William Pao, Yumei Pan, Lu Wang, 2012, Proceedings of the National Academy of Sciences.

Inhibition of mTOR by temsirolimus contributes to prolonged survival of mice with pleural dissemination of non‐small‐cell lung cancer cells

S. Toyooka, T. Fujiwara, N. Tanaka, 2011, Cancer science.

EGFR mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib-treated patients with lung adenocarcinoma

J. Soh, S. Toyooka, K. Matsuo, 2009 .

Epidermal growth factor receptor mutation, but not sex and smoking, is independently associated with favorable prognosis of gefitinib‐treated patients with lung adenocarcinoma

J. Soh, S. Toyooka, K. Matsuo, 2008, Cancer science.

Clinical Significance of Epidermal Growth Factor Receptor Gene Mutations on Treatment Outcome after First-line Cytotoxic Chemotherapy in Japanese Patients with Non-small Cell Lung Cancer

J. Soh, S. Toyooka, K. Kiura, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Usefulness of EGFR mutation screening in pleural fluid to predict the clinical outcome of gefitinib treated patients with lung cancer

J. Soh, S. Toyooka, K. Kiura, 2006, International journal of cancer.

Clinical features and outcomes of patients with stage I multiple primary lung cancers

E. Miyaoka, S. Toyooka, H. Asamura, 2020, Cancer science.

Decreased expression of the SIN3A gene, a candidate tumor suppressor located at the prevalent allelic loss region 15q23 in non-small cell lung cancer.

Nobuyoshi Shimizu, Kenji Shimizu, Hiroshi Date, 2008, Lung cancer.

Tumor‐specific exon creation of the HELLS/SMARCA6 gene in non‐small cell lung cancer

S. Toyooka, H. Shigematsu, M. Yano, 2004, International journal of cancer.

Establishment and Validation of Quantitative Real-time PCR Assay for Aberrant Methylation of 14-3-3σ Gene in Breast and Lung Carcinoma.

S. Toyooka, A. Gazdar, E. Brambilla, 2004, Cancer genomics & proteomics.

Epigenetic inactivation of laminin-5-encoding genes in lung cancers.

J. Minna, S. Toyooka, A. Gazdar, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors

W. Lam, J. Minna, J. Soh, 2009, International journal of cancer.

ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer.

J. Soh, S. Toyooka, K. Kiura, 2008, Lung cancer.

Usefulness of Thoracoscopic Debridement for Chronic Empyema after an Extrapleural Pneumonectomy.

J. Soh, S. Toyooka, S. Miyoshi, 2016, Acta medica Okayama.

Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Lung cancer.

Critical role of the MCAM-ETV4 axis triggered by extracellular S100A8/A9 in breast cancer aggressiveness

J. Soh, S. Toyooka, Hiroki Sato, 2019, Neoplasia.

Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus Cisplatin for Completely Resected Stage II to IIIA Nonsquamous Non-Small-Cell Lung Cancer.

S. Toyooka, M. Tsuboi, T. Yamanaka, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antitumor activity of pan‐HER inhibitors in HER2‐positive gastric cancer

J. Soh, S. Toyooka, K. Tsukuda, 2018, Cancer science.

Negative impact of recipient SPRED2 deficiency on transplanted lung in a mouse model.

S. Toyooka, A. Matsukawa, T. Yoshimura, 2019, Transplant immunology.

The Impact of Sex and Smoking Status on the Mutational Spectrum of Epidermal Growth Factor Receptor Gene in Non–small Cell Lung Cancer

J. Soh, S. Toyooka, I. Wistuba, 2007, Clinical Cancer Research.

Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation

S. Toyooka, Shinsuke Hashida, K. Suzawa, 2018, Scientific Reports.

Pneumocephalus and chylothorax complicating vertebrectomy for lung cancer.

S. Toyooka, S. Miyoshi, K. Suzawa, 2015, The Annals of thoracic surgery.

Asymptomatic but functional paraganglioma of the posterior mediastinum.

S. Toyooka, S. Miyoshi, K. Suzawa, 2014, The Annals of thoracic surgery.

The prognostic nutritional index is correlated negatively with the lung allocation score and predicts survival after both cadaveric and living-donor lobar lung transplantation

J. Soh, S. Toyooka, M. Okazaki, 2021, Surgery Today.

Contralateral pneumothorax in bullous lung after pneumonectomy: report of two cases

J. Soh, S. Toyooka, S. Miyoshi, 2012, General Thoracic and Cardiovascular Surgery.

Hsp90 inhibitor NVP-AUY922 enhances the radiation sensitivity of lung cancer cell lines with acquired resistance to EGFR-tyrosine kinase inhibitors.

J. Soh, S. Toyooka, S. Miyoshi, 2015, Oncology reports.

Drug resistance to EGFR tyrosine kinase inhibitors for non-small cell lung cancer.

J. Soh, S. Toyooka, S. Miyoshi, 2014, Acta medica Okayama.

Mechanisms and Overcome of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

J. Soh, S. Toyooka, S. Miyoshi, 2012 .

The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitor.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Lung cancer.

Smoke exposure, histologic type and geography‐related differences in the methylation profiles of non‐small cell lung cancer

J. Minna, S. Toyooka, J. Roth, 2003, International journal of cancer.

Effectiveness of scheduled intravenous acetaminophen in the postoperative pain management of video-assisted thoracic surgery

J. Soh, S. Toyooka, K. Shien, 2020, Surgery Today.

Ethnicity affects EGFR and KRAS gene alterations of lung adenocarcinoma.

S. Lam, J. Soh, S. Toyooka, 2015, Oncology letters.

Acquisition of cancer stem cell-like properties in non-small cell lung cancer with acquired resistance to afatinib

J. Soh, S. Toyooka, S. Miyoshi, 2015, Cancer science.

Silenced expression of NFKBIA in lung adenocarcinoma patients with a never-smoking history.

J. Soh, S. Toyooka, S. Miyoshi, 2013, Acta medica Okayama.

Tumor-suppressive effect of LRIG1, a negative regulator of ErbB, in non-small cell lung cancer harboring mutant EGFR

J. Soh, S. Toyooka, S. Miyoshi, 2018, Carcinogenesis.

Tumor-suppressive effect of LRIG 1 in lung cancer

J. Soh, S. Toyooka, S. Miyoshi, 2022 .

The impact of epidermal growth factor receptor gene status on gefitinib‐treated Japanese patients with non‐small‐cell lung cancer

J. Soh, S. Toyooka, Masaki Tokumo, 2007, International journal of cancer.

Impact of GLUT1 and Ki-67 expression on early‑stage lung adenocarcinoma diagnosed according to a new international multidisciplinary classification.

J. Soh, S. Toyooka, S. Miyoshi, 2013, Oncology reports.

Usefulness of cumulative smoking dose for identifying the EGFR mutation and patients with non‐small‐cell lung cancer for gefitinib treatment

S. Toyooka, S. Miyoshi, K. Matsuo, 2009, Cancer science.

Impact of EGFR mutation analysis in non-small cell lung cancer.

S. Toyooka, T. Mitsudomi, H. Yamamoto, 2009, Lung cancer.

Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib.

J. Soh, S. Toyooka, K. Kiura, 2008, Lung cancer.

Impact of HER2 and EGFR gene status on gefitinib‐treated patients with nonsmall‐cell lung cancer

J. Soh, S. Toyooka, K. Kiura, 2007, International journal of cancer.

EGFR mutation status in pleural fluid predicts tumor responsiveness and resistance to gefitinib.

J. Soh, S. Toyooka, K. Kiura, 2007, Lung cancer.

EGFR mutation and response of lung cancer to gefitinib.

S. Toyooka, T. Mitsudomi, K. Kiura, 2005, The New England journal of medicine.

A new human lung adenocarcinoma cell line harboring the EML4-ALK fusion gene.

S. Toyooka, K. Kiura, M. Tanimoto, 2014, Japanese journal of clinical oncology.

Genetic alterations in lung adenocarcinoma with a micropapillary component.

J. Soh, S. Toyooka, S. Miyoshi, 2016, Molecular and clinical oncology.

Antitumor effect of afatinib , as a HER 2-targeted therapy , in lung cancers harboring HER 2 oncogene alterations

J. Soh, S. Toyooka, S. Miyoshi, 2015 .

Anti-Cancer Effects of REIC/Dkk-3-encoding Adenoviral Vector for the Treatment of Non-small Cell Lung Cancer

J. Soh, S. Toyooka, S. Miyoshi, 2014, PloS one.

Overcoming epithelial-mesenchymal transition-mediated drug resistance with monensin-based combined therapy in non-small cell lung cancer.

S. Toyooka, T. Shien, S. Tomida, 2020, Biochemical and biophysical research communications.

The Epidermal Growth Factor Receptor D761Y Mutation and Effect of Tyrosine Kinase Inhibitor

S. Toyooka, K. Kiura, H. Date, 2007, Clinical Cancer Research.

Mutations of epidermal growth factor receptor and K‐ras genes in adenosquamous carcinoma of the lung

S. Toyooka, Y. Yatabe, T. Mitsudomi, 2006, International journal of cancer.

Antitumor effect of afatinib, as a human epidermal growth factor receptor 2‐targeted therapy, in lung cancers harboring HER2 oncogene alterations

J. Soh, S. Toyooka, S. Miyoshi, 2015, Cancer Science.

Long-term outcome of induction chemoradiotherapy with docetaxel and cisplatin followed by surgery for non-small-cell lung cancer with mediastinal lymph node metastasis.

S. Toyooka, S. Miyoshi, K. Kiura, 2012, Interactive cardiovascular and thoracic surgery.

Allele-specific role of ERBB2 in the oncogenic function of EGFR L861Q in EGFR-mutant lung cancers.

M. Ladanyi, M. Kris, S. Toyooka, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Study Protocol: Phase‐Ib Trial of Nivolumab Combined With Metformin for Refractory/Recurrent Solid Tumors

S. Toyooka, K. Kiura, T. Fujiwara, 2018, Clinical lung cancer.

Impact of age on epidermal growth factor receptor mutation in lung cancer.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Lung cancer.

Presence of EGFR mutation in pathologically non-malignant specimens from computed tomography-guided lung needle biopsies.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Oncology letters.

DV200 Index for Assessing RNA Integrity in Next-Generation Sequencing

J. Soh, S. Toyooka, S. Tomida, 2020, BioMed research international.

STAT3 expression in activating EGFR-driven adenocarcinoma of the lung.

S. Toyooka, K. Kiura, M. Tanimoto, 2012, Lung cancer.

Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib‐resistance in cells carrying EGFR mutation

S. Toyooka, K. Kiura, M. Tabata, 2007, Cancer science.

Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer

J. Soh, S. Toyooka, T. Shien, 2019, AntiCancer Research.

Presence of the minor EGFR T790M mutation is associated with drug-sensitive EGFR mutations in lung adenocarcinoma patients.

J. Soh, S. Toyooka, S. Miyoshi, 2014, Oncology reports.

JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer

Jing Wang, J. Minna, S. Toyooka, 2017, Molecular Cancer Therapeutics.

1 JAK 1 / STAT 3 activation through a proinflammatory cytokine pathway leads to resistance to molecularly targeted therapy in non-small cell lung cancer

Jing Wang, J. Minna, S. Toyooka, 2017 .

SYT-SSX fusion genes in synovial sarcoma of the thorax.

S. Toyooka, M. Aoe, K. Ichimura, 2004, Lung cancer.

Relationships of physical and breast cancer phenotypes with three single-nucleotide polymorphisms (rs2046210, rs3757318, and rs3803662) associated with breast cancer risk in Japanese women

Hirokuni Ikeda, N. Taira, S. Toyooka, 2020, Breast Cancer.

Lung perfusion scintigraphy to detect chronic lung allograft dysfunction after living-donor lobar lung transplantation

S. Toyooka, M. Okazaki, S. Sugimoto, 2020, Scientific Reports.

Knockdown of the epidermal growth factor receptor gene to investigate its therapeutic potential for the treatment of non-small-cell lung cancers.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Clinical lung cancer.

Long-term clinical follow-up after lung transplantation in patient with scoliosis: a case report

S. Toyooka, S. Sugimoto, K. Miyoshi, 2020, General Thoracic and Cardiovascular Surgery.

Antitumor effect of gefitinib ('Iressa') on esophageal squamous cell carcinoma cell lines in vitro and in vivo.

N. Taira, F. Hara, S. Toyooka, 2005, Cancer letters.

Suv4-20h2 protects against influenza virus infection by suppression of chromatin loop formation

T. Itoh, K. Shirahige, S. Toyooka, 2021, iScience.

Open Access Research Article

Hirokuni Ikeda, N. Taira, F. Hara, 2022 .

Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Lung cancer.

RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.

J. Minna, S. Toyooka, A. Gazdar, 2004, Cancer research.

Poor vaccine responsiveness towards third-dose mRNA vaccine of COVID-19 in Japanese older people

S. Toyooka, T. Yorifuji, H. Hagiya, 2022, Journal of Infection.

Study about the Efficacy of Metformin to Immune Function in Cancer Patients.

J. Soh, S. Toyooka, T. Shien, 2016, Acta medica Okayama.

Differential expression of FEZ1/LZTS1 gene in lung cancers and their cell cultures.

J. Minna, S. Toyooka, I. Wistuba, 2002, Clinical Cancer Research.

Activations of mitogen-activated protein kinases and regulation of their downstream molecules after rat lung transplantation from donors after cardiac death.

S. Toyooka, S. Miyoshi, M. Okazaki, 2011, Transplantation proceedings.

Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.

S. Toyooka, H. Doihara, M. Toyota, 2004, Oncology reports.

Low Frequency of Drug-Resistant virus did not Affect the Therapeutic Efficacy in Daclatasvir plus Asunaprevir Therapy in Patients with Chronic HCV Genotype-1 Infection

S. Toyooka, H. Shiraha, A. Takaki, 2016, Antiviral therapy.

Influences of preoperative metformin on immunological factors in early breast cancer

Hirokuni Ikeda, N. Taira, S. Toyooka, 2020, Cancer Chemotherapy and Pharmacology.

Role of surgery in a novel multimodal therapeutic approach to complete cure of advanced lung cancer: current and future perspectives

S. Toyooka, M. Yamane, 2021, Surgery Today.

Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301

J. Soh, S. Toyooka, K. Matsuo, 2021, BMC cancer.

A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil‐Tegafur as the Adjuvant Chemotherapy in Resected Non–Small Cell Lung Cancer

J. Soh, S. Toyooka, S. Miyoshi, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Feasibility of adjuvant chemotherapy with S-1 plus carboplatin followed by single-agent maintenance therapy with S-1 for completely resected non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 1001

J. Soh, S. Toyooka, K. Matsuo, 2017, International Journal of Clinical Oncology.

Adjuvant chemotherapy for completely resected non-small-cell lung cancer.

S. Toyooka, H. Suehisa, Hiroshi Suehisa, 2009, Acta medica Okayama.

Epidermal growth factor receptor mutation status and adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.

J. Soh, S. Toyooka, K. Matsuo, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Active Secretion of Dimerized S100A11 Induced by the Peroxisome in Mesothelioma Cells

J. Soh, S. Toyooka, M. Sakaguchi, 2016, Cancer Microenvironment.

Adult mesenchymal hamartoma of the chest wall: report of a case.

J. Soh, S. Toyooka, S. Miyoshi, 2014, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Lung cancer.

Pulmonary resection in a prone position for lung cancer invading the spine

J. Soh, S. Toyooka, K. Shien, 2019, General Thoracic and Cardiovascular Surgery.

S. Toyooka, Jun Kato, K. Kuwaki, 2008, Clinical biochemistry.

Surgical Treatment for N2 Non-small Cell Lung Cancer

S. Toyooka, S. Sugimoto, 2019 .

Aberrant methylation of HIN‐1 (high in normal‐1) is a frequent event in many human malignancies

S. Toyooka, A. Gazdar, B. Czerniak, 2005, International journal of cancer.

Primary pulmonary melanoma: a report of two cases

J. Soh, S. Toyooka, S. Miyoshi, 2015, World Journal of Surgical Oncology.

Radiofrequency ablation of lung cancer at Okayama University Hospital: a review of 10 years of experience.

Takao Hiraki, Hidefumi Mimura, Susumu Kanazawa, 2011, Acta Medica Okayama.

Toll-like receptor 4 promotes bladder cancer progression upon S100A8/A9 binding, which requires TIRAP-mediated TPL2 activation.

S. Toyooka, M. Sakaguchi, E. Kondo, 2022, Biochemical and biophysical research communications.

Surgical resection of a massive primary mediastinal liposarcoma using clamshell incision combined with lower median sternotomy: report of a case.

S. Toyooka, S. Miyoshi, K. Ichimura, 2014, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Paediatric lung transplantation: the impact of age on the survival

S. Toyooka, K. Suzawa, M. Okazaki, 2022, Surgery Today.

Novel Germline Mutation in the Transmembrane Domain of HER2 in Familial Lung Adenocarcinomas

J. Soh, S. Toyooka, S. Miyoshi, 2013, Journal of the National Cancer Institute.

Diagnostic value of circulating microRNA-21 in chronic lung allograft dysfunction after bilateral cadaveric and living-donor lobar lung transplantation.

S. Toyooka, K. Shien, K. Suzawa, 2023, Heliyon.

Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil–tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial

J. Soh, S. Toyooka, M. Aoe, 2019, International Journal of Clinical Oncology.

Resection of the entire first rib for fibrous dysplasia using a combined posterior-transmanubrial approach

J. Soh, S. Toyooka, S. Miyoshi, 2012, General Thoracic and Cardiovascular Surgery.

LOXL1 and LOXL4 are novel target genes of the Zn2+-bound form of ZEB1 and play a crucial role in the acceleration of invasive events in triple-negative breast cancer cells

S. Toyooka, M. Sakaguchi, Ken‐ichi Yamamoto, 2023, Frontiers in Oncology.

Reconstruction of Anterior Chest Wall with Polypropylene Mesh: Two Primary Sternal Chondrosarcoma Cases.

S. Toyooka, S. Miyoshi, S. Sugimoto, 2017, Acta medica Okayama.

Unique circulating microRNAs in relation to EGFR mutation status in Japanese smoker male with lung adenocarcinoma

S. Toyooka, Kaori Sasai, H. Katayama, 2017, Oncotarget.

Bronchial healing after living-donor lobar lung transplantation

S. Toyooka, H. Date, Y. Sano, 2009, Surgery Today.

Expert consensus recommendations on biomarker testing in metastatic and non-metastatic non-small cell lung cancer in Asia.

Jie Yang, S. Toyooka, Y. Yatabe, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia

Jie Yang, S. Toyooka, Y. Yatabe, 2022 .

Sarcopenia is associated with poor prognosis after chemoradiotherapy in patients with stage III non-small-cell lung cancer: a retrospective analysis

S. Toyooka, K. Kiura, M. Kuroda, 2021, Scientific Reports.

Sarcopenia is related to poor prognosis in patients after trimodality therapy for locally advanced non-small cell lung cancer

S. Toyooka, K. Kiura, M. Kuroda, 2021, International Journal of Clinical Oncology.

The neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple metastatic lung tumors from various sarcomas

J. Soh, S. Toyooka, K. Shien, 2020, Surgery Today.

Impact of aberrant methylation of microRNA-9 family members on non-small cell lung cancers.

J. Soh, S. Toyooka, S. Miyoshi, 2013, Molecular and clinical oncology.

Recurrent lung cancer in the mediastinum noticed after a living-donor lobar lung transplantation.

S. Toyooka, H. Date, Y. Sano, 2009, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Case Report Recurrent Lung Cancer in the Mediastinum Noticed after a Living-Donor Lobar Lung Transplantation

S. Toyooka, H. Date, Y. Sano, 2009 .

Frequent silencing of tumor-suppressive miR-34b/c by aberrant methylation in malignant pleural mesothelioma

S. Toyooka, S. Miyoshi, Takafumi Kubo, 2012 .

Early postoperative complications after middle lobe-preserving surgery for secondary lung cancer

J. Soh, S. Toyooka, S. Miyoshi, 2017, Surgery Today.

Bronchoplasty to adjust mismatches in the proximal and distal bronchial stumps during bronchial sleeve resection of the left lower lobe and lingular division.

J. Soh, S. Toyooka, S. Miyoshi, 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

OP-EUJC230049 1..9

S. Toyooka, K. Shien, Mototsugu Watanabe, 2023 .

Sacrificing the pulmonary arterial branch to the spared lobe is a risk factor of bronchopleural fistula in sleeve lobectomy after chemoradiotherapy.

J. Soh, S. Toyooka, S. Miyoshi, 2013, European Journal of Cardio-Thoracic Surgery.

Induction therapy followed by surgery for non small-cell lung cancer

S. Toyooka, 2014 .

The Need for an Individual Approach to Lung Cancer Treatment

S. Toyooka, H. Shigematsu, Makoto Suzuki, 2006, PLoS medicine.

Role of surgery in N2 NSCLC: pros.

S. Toyooka, K. Shien, 2016, Japanese journal of clinical oncology.

A multicenter, phase III study of carboplatin/paclitaxel versus oral uracil-tegafur as the adjuvant chemotherapy in resected non-small cell lung cancer (NSCLC): Planned interim analyses.

S. Toyooka, M. Aoe, J. Sakamoto, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

S100A8/A9 as a prognostic biomarker in lung transplantation

S. Toyooka, K. Shien, K. Suzawa, 2023, Clinical transplantation.

Meticulous closure of collateral vessels in the perihilar mediastinal pleura to control intraoperative bleeding during lung transplantation for pulmonary hypertension

S. Toyooka, S. Sugimoto, K. Miyoshi, 2021, Journal of thoracic disease.

Protective effects of anti-HMGB1 monoclonal antibody on lung ischemia reperfusion injury in mice.

S. Toyooka, K. Shien, K. Suzawa, 2021, Biochemical and biophysical research communications.

Long-term outcomes of living-donor lobar lung transplantation.

S. Toyooka, H. Date, S. Sugimoto, 2021, The Journal of thoracic and cardiovascular surgery.

Donor's long‐term quality of life following living‐donor lobar lung transplantation

S. Toyooka, K. Shien, K. Suzawa, 2023, Clinical transplantation.

HD-PTP: A novel protein tyrosine phosphatase gene on human chromosome 3p21.3.

S. Toyooka, K. Tsukuda, M. Ouchida, 2000, Biochemical and biophysical research communications.

Detection of airway ischaemic damage after lung transplantation by using autofluorescence imaging bronchoscopy.

S. Toyooka, S. Miyoshi, S. Sugimoto, 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Airway complications have a greater impact on the outcomes of living-donor lobar lung transplantation recipients than cadaveric lung transplantation recipients

S. Toyooka, S. Sugimoto, T. Oto, 2018, Surgery Today.

Differential Expression of FEZ 1 / LZTS 1 Gene in Lung Cancers and Their Cell Cultures 1

J. Minna, S. Toyooka, I. Wistuba, 2002 .

Radiofrequency ablation of pulmonary tumors near the diaphragm.

S. Toyooka, T. Mitsuhashi, S. Kanazawa, 2017, Diagnostic and interventional imaging.

Radiofrequency Ablation of Lung Tumors Using a Multitined Expandable Electrode: Impact of the Electrode Array Diameter on Local Tumor Progression.

J. Soh, S. Toyooka, S. Kanazawa, 2016, Journal of vascular and interventional radiology : JVIR.

Combined effect of cabozantinib and gefitinib in crizotinib‐resistant lung tumors harboring ROS1 fusions

S. Toyooka, K. Kiura, M. Tabata, 2018, Cancer science.

A phase 2 basket trial of combination therapy with trastuzumab and pertuzumab in patients with solid cancers harboring human epidermal growth factor receptor 2 amplification (JUPITER trial)

S. Toyooka, S. Ikeda, C. Ishioka, 2020, Medicine.

Spontaneous regression of primary lung cancer arising from an emphysematous bulla.

S. Toyooka, S. Miyoshi, K. Kiura, 2011, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

S. Toyooka, T. Mitsudomi, M. Satouchi, 2019 .

MDT lung cancer care: Input from the Surgical Oncologist

S. Toyooka, K. Yasufuku, B. Kidane, 2015, Respirology.

Induction chemoradiotherapy prior to surgery for non-small cell lung cancer invading the left atrium.

S. Toyooka, K. Kiura, H. Date, 2008, European Journal of Cardio-Thoracic Surgery.

Therapeutic strategies for afatinib‐resistant lung cancer harboring HER2 alterations

J. Soh, S. Toyooka, S. Miyoshi, 2018, Cancer science.

Conditional blastocyst complementation of a defective Foxa2 lineage efficiently promotes generation of the whole lung

S. Toyooka, J. Que, Chyuan-Sheng Lin, 2023, bioRxiv.

Foxa2 lineage + mesendoderm forms a competitive pulmonary mesenchyme niche crucial for generating the entire lungs

S. Toyooka, J. Que, Chyuan-Sheng Lin, 2022 .

Melanoma cell adhesion molecule is the driving force behind the dissemination of melanoma upon S100A8/A9 binding in the original skin lesion.

J. Soh, S. Toyooka, Kaori Sasai, 2019, Cancer letters.

The relationship between aberrant methylation and survival in non-small-cell lung cancers

S. Toyooka, A. Gazdar, M. Aoe, 2004, British Journal of Cancer.

SRC Family Kinase Inhibition Targets YES1 and YAP1 as Primary Drivers of Lung Cancer and as Mediators of Acquired Resistance to ALK and Epidermal Growth Factor Receptor Inhibitors

M. Ladanyi, S. Toyooka, Gregory Riely, 2022, JCO precision oncology.

Lysyl oxidase-like 4 exerts an atypical role in breast cancer progression that is dependent on the enzymatic activity that targets the cell-surface annexin A2

S. Toyooka, M. Sakaguchi, Y. Sakaguchi, 2023, Frontiers in Oncology.

Continuing surgical education of non-technical skills

J. Soh, S. Toyooka, T. Yorifuji, 2020, Annals of medicine and surgery.

Wedge Resection of the Bronchial Corner at the Bifurcation of the Lobar Bronchi for a Low-Grade Bronchial Tumor

S. Toyooka, S. Miyoshi, H. Yamamoto, 2012, Thoracic and Cardiovascular Surgeon.

Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial.

Kenji Suzuki, S. Toyooka, S. Miyoshi, 2023, The Lancet. Respiratory medicine.

Prophylactic use of ofloxacin in granulocytopenic patients with hematological malignancies during post-remission chemotherapy.

S. Toyooka, H. Iwasaki, T. Fukushima, 1992, Internal medicine.

CT fluoroscopy-guided biopsy of 1,000 pulmonary lesions performed with 20-gauge coaxial cutting needles: diagnostic yield and risk factors for diagnostic failure.

S. Toyooka, S. Kanazawa, Y. Sano, 2009, Chest.

CD8+ T-cell responses are boosted by dual PD-1/VEGFR2 blockade after EGFR inhibition in Egfr-mutant lung cancer.

S. Toyooka, K. Kiura, M. Tabata, 2022, Cancer immunology research.

Neuroplastin‐β mediates S100A8/A9‐induced lung cancer disseminative progression

J. Soh, S. Toyooka, M. Sakaguchi, 2019, Molecular carcinogenesis.

Restrictive ventilatory impairment is associated with poor outcome in patients with cT1aN0M0 peripheral squamous cell carcinoma of the lung.

J. Soh, S. Toyooka, S. Miyoshi, 2017, Journal of thoracic disease.

Upregulation of mobility in pancreatic cancer cells by secreted S100A11 through activation of surrounding fibroblasts.

S. Toyooka, M. Sakaguchi, Chen Youyi, 2019, Oncology research.

Extracellular S100A11 Plays a Critical Role in Spread of the Fibroblast Population in Pancreatic Cancers.

S. Toyooka, M. Sakaguchi, E. Kondo, 2019, Oncology research.

Dose-Volume Parameters Predict Radiation Pneumonitis after Surgery with Induction Concurrent Chemoradiotherapy for Non-small Cell Lung Cancer.

J. Soh, S. Toyooka, K. Kiura, 2018, Acta medica Okayama.

Induction chemoradiotherapy is superior to induction chemotherapy for the survival of non-small-cell lung cancer patients with pathological mediastinal lymph node metastasis.

S. Toyooka, S. Miyoshi, K. Kiura, 2012, Interactive cardiovascular and thoracic surgery.

MicroRNA miR-34b/c enhances cellular radiosensitivity of malignant pleural mesothelioma cells.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Anticancer research.

Diaphragmatic hernia after percutaneous radiofrequency ablation of lung tumor.

S. Toyooka, S. Kanazawa, H. Gobara, 2011, Journal of vascular and interventional radiology : JVIR.

Chemoradiation therapy for non-small cell lung cancer exacerbates thoracic aortic calcification determined by computed tomography

J. Soh, S. Toyooka, K. Kiura, 2020, Heart and Vessels.

Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines

F. Hara, S. Toyooka, Masaki Tokumo, 2007, BMC Cancer.

Robotic Mediastinal Tumor Resections: Position and Port Placement

S. Toyooka, K. Shien, K. Suzawa, 2022, Journal of personalized medicine.

Myoepithelioma occurring in the posterior mediastinum harboring EWSR1 rearrangement: a case report.

J. Soh, S. Toyooka, K. Shien, 2018, Japanese journal of clinical oncology.

Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis

J. Soh, S. Toyooka, K. Kiura, 2019, BMC Cancer.

Preclinical evaluation of microRNA-34b/c delivery for malignant pleural mesothelioma.

J. Soh, S. Toyooka, S. Miyoshi, 2014, Acta medica Okayama.

Thoracoscopic lobectomy as salvage surgery for local recurrence of non-small cell lung cancer after carbon ion radiotherapy in an initially operable patient.

S. Toyooka, S. Miyoshi, K. Ichimura, 2014, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Mortality from extrathymic malignancy after thymic tumour resections: incidences and risk factors.

S. Toyooka, H. Date, K. Kondo, 2019, Interactive cardiovascular and thoracic surgery.

Kissing-stents technique after living-donor lobar lung transplantation.

S. Toyooka, S. Miyoshi, S. Sugimoto, 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Influence of breast density on breast cancer risk: a case control study in Japanese women

Hirokuni Ikeda, N. Taira, S. Toyooka, 2019, Breast Cancer.

Computed tomography fluoroscopy-guided cutting needle biopsy of pulmonary nodules ≤8 mm: A retrospective study including 117 nodules.

S. Toyooka, S. Kanazawa, H. Gobara, 2020, European journal of radiology.

Mutation analysis of the BRAF codon 599 in malignant pleural mesothelioma by enriched PCR-RFLP.

S. Toyooka, H. Pass, M. Yano, 2004, Oncology reports.

Safety of salvage lung resection after immunotherapy for unresectable non-small cell lung cancer

S. Toyooka, Y. Sano, M. Okazaki, 2022, General Thoracic and Cardiovascular Surgery.

A Surgical Instructor Training Course for the Next Generation.

S. Toyooka, A. Matsukawa, M. Yamane, 2020, Acta Medica Okayama.

The effect of epidermal growth factor receptor antisense morpholino oligomer on non-small cell lung cancer cell line.

S. Toyooka, M. Aoe, K. Tsukuda, 2003, Oncology reports.

Elderly lung transplant recipients show acceptable long-term outcomes for lung transplantation: A propensity score-matched analysis.

S. Toyooka, M. Okazaki, S. Sugimoto, 2023, Surgery today.

Abstract 724: Anti-tumor effect of Dasatinib in HER2 positive breast cancer with Trastuzumab resistance

J. Soh, S. Toyooka, S. Miyoshi, 2015 .

Effects of Cold Ischemia on RNA Stability and Quality of Lung Tissues Based on Standard PREanalytical Code Categorization.

J. Soh, S. Toyooka, S. Tomida, 2017, Biopreservation and Biobanking.

Alterations in the mitochondrial displacement loop in lung cancers.

S. Toyooka, A. Gazdar, T. Iizasa, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Robot-assisted intrathoracic procedure for dumbbell tumour in the prone position.

S. Toyooka, K. Suzawa, T. Takigawa, 2021, Interactive cardiovascular and thoracic surgery.

Percentage of low attenuation area on computed tomography detects chronic lung allograft dysfunction, especially bronchiolitis obliterans syndrome, after bilateral lung transplantation

S. Toyooka, K. Shien, K. Suzawa, 2023, Clinical transplantation.

The impact of EGFR mutation and smoking status on non-small-cell lung cancer patients treated with geftinib: A5-04

J. Soh, S. Toyooka, Y. Yatabe, 2007 .

Basal segmental auto-transplantation after pneumonectomy for advanced central lung cancer.

S. Toyooka, S. Miyoshi, K. Kiura, 2012, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Long-term outcomes following surgical treatment for thymic epithelial tumor in Japan and an analysis of prognostic factors based on the Japanese Association for Research on the Thymus nationwide database

S. Toyooka, M. Tsuboi, H. Asamura, 2023, Surgery Today.

Induction Chemoradiotherapy Followed by Surgical Resection for Clinical T3 or T4 Locally Advanced Non–Small Cell Lung Cancer

J. Soh, S. Toyooka, S. Miyoshi, 2012, Annals of Surgical Oncology.

Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non–small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701

J. Soh, S. Toyooka, K. Matsuo, 2016, Japanese journal of clinical oncology.

Survival Outcomes of Treatment with Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients with Clinical Stage I Non-Small-Cell Lung Cancer: A Single-Center Evaluation.

J. Soh, S. Toyooka, S. Kanazawa, 2020, Journal of vascular and interventional radiology : JVIR.

Randomized phase II study of daily versus alternate-day administrations of S-1 for the elderly patients with completely resected pathological stage IA (tumor diameter > 2 cm)—IIIA of non-small cell lung cancer: Setouchi Lung Cancer Group Study 1201

J. Soh, S. Toyooka, K. Matsuo, 2023, PloS one.

Favorable survival even with high disease‐specific complication rates in lymphangioleiomyomatosis after lung transplantation—long‐term follow‐up of a Japanese center

S. Toyooka, M. Okazaki, S. Sugimoto, 2019, The clinical respiratory journal.

Relationship between epidermal growth factor receptor gene mutations and the severity of adverse events by gefitinib in patients with advanced non-small cell lung cancer.

S. Toyooka, K. Matsuo, Masaki Tokumo, 2006, Lung cancer.

Extracorporeal membrane oxygenation bridging to living-donor lobar lung transplantation.

S. Toyooka, S. Miyoshi, Y. Sano, 2009, The Annals of thoracic surgery.

Chronic lung injury after trimodality therapy for locally advanced non-small cell lung cancer.

J. Soh, S. Toyooka, K. Kiura, 2020, The Annals of thoracic surgery.

A Multicenter Randomized Controlled Study of Paclitaxel plus Carboplatin versus Oral Uracil-Tegafur as the Adjuvant Chemotherapy in Resected Non-Small Cell Lung Cancer

J. Soh, S. Toyooka, S. Miyoshi, 2018 .

Lower lobe origin is a poor prognostic factor in locally advanced non-small-cell lung cancer patients treated with induction chemoradiotherapy.

J. Soh, S. Toyooka, S. Miyoshi, 2015, Molecular and clinical oncology.

Trimodality therapy consisting of induction chemoradiotherapy (CRT) followed by surgery is a potential treatment option for locally advanced non-small-cell lung cancer (NSCLC). Two randomized phase III trials investigated the prognostic effect of surgery following induction CRT in patients with medi

J. Soh, S. Toyooka, S. Miyoshi, 2015 .

Living-donor lobar lung transplantation

S. Toyooka, H. Date, Y. Sano, 2007 .

Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery

J. Soh, S. Toyooka, K. Kiura, 2018, Japanese journal of clinical oncology.

Prognostic factors for lung transplant recipients focusing on age and gender: the Japanese lung transplantation report 2022

S. Toyooka, H. Date, T. Nagayasu, 2023, Surgery Today.

A Case of Carcinoma Showing Thymus-Like Differentiation with a Rapidly Lethal Course

N. Taira, J. Soh, S. Toyooka, 2014, Case Reports in Oncology.

Robot-assisted thoracoscopic lobectomy for severe incomplete interlober fissure

S. Toyooka, K. Shien, K. Suzawa, 2021, Journal of Surgical Case Reports.

The impact of prognostic nutrition index on the waitlist mortality of lung transplantation

S. Toyooka, M. Okazaki, S. Sugimoto, 2022, General Thoracic and Cardiovascular Surgery.

Massive Subcutaneous and Mediastinal Emphysema with Little Pneumothorax Treated by Surgery after Pulmonary Radiofrequency Ablation

J. Soh, S. Toyooka, S. Miyoshi, 2014, CardioVascular and Interventional Radiology.

Staged surgery for empyema and lung gangrene caused by pseudoaneurysm after radiofrequency ablation.

S. Toyooka, S. Sugimoto, M. Yamane, 2021, Interactive cardiovascular and thoracic surgery.

OP-ICVA200331 831..833

S. Toyooka, S. Sugimoto, M. Yamane, 2021 .

OP-ICVA200331 1..3

S. Toyooka, S. Sugimoto, M. Yamane, 2021 .

Comparative mutational evaluation of multiple lung cancers by multiplex oncogene mutation analysis

J. Soh, S. Toyooka, S. Tomida, 2018, Cancer science.

Induction S-1+Concurrent Radiotherapy Followed by Surgical Resection of Locally Advanced Non-small-cell Lung Cancer in an Elderly Patient.

J. Soh, S. Toyooka, S. Miyoshi, 2016, Acta Medica Okayama.

Predicting pleural invasion using HRCT and 18F-FDG PET/CT in lung adenocarcinoma with pleural contact

J. Soh, S. Toyooka, S. Miyoshi, 2015, Annals of Nuclear Medicine.

Phase Ib trial of nivolumab combined with metformin for refractory/recurrent solid tumors.

S. Toyooka, K. Kiura, T. Fujiwara, 2018 .

[Intrathoracic vagal nerve schwannoma preoperative diagnosis is correct because of clinical and characteristic CT findings--a case report and review of the literature].

S. Toyooka, H. Maeda, M. Kaji, 1998, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

Acquired resistance mechanisms to afatinib in HER2‐amplified gastric cancer cells

J. Soh, S. Toyooka, S. Tomida, 2019, Cancer science.

Promoter methylation downregulates CDX2 expression in colorectal carcinomas.

S. Toyooka, K. Tomii, M. Yano, 2005, Oncology reports.

Lung transplantation for Kartagener syndrome: technical aspects and morphological adaptation of the transplanted lungs

S. Toyooka, S. Sugimoto, K. Miyoshi, 2020, General Thoracic and Cardiovascular Surgery.

MET gene amplification or EGFR mutation activate MET in lung cancers untreated with EGFR tyrosine kinase inhibitors

W. Lam, J. Minna, J. Soh, 2009, International journal of cancer.

The epidermal growth factor receptor D761Y mutation and effect of tyrosine kinase inhibitor. Authors' reply

S. Toyooka, W. Pao, K. Kiura, 2007 .

The degree of microRNA-34b/c methylation in serum-circulating DNA is associated with malignant pleural mesothelioma.

J. Soh, S. Toyooka, S. Miyoshi, 2013, Lung cancer.

Epigenetic Silencing of MicroRNA-34b/c Plays an Important Role in the Pathogenesis of Malignant Pleural Mesothelioma

J. Soh, S. Toyooka, S. Miyoshi, 2011, Clinical Cancer Research.

Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.

J. Soh, S. Toyooka, S. Miyoshi, 2012, Lung cancer.

Hereditary Lung Cancer Syndrome Targets Never Smokers with Germline EGFR Gene T790M Mutations

J. Soh, S. Toyooka, W. Travis, 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers.

J. Minna, S. Toyooka, J. Roth, 2006, Journal of the National Cancer Institute.

Establishment and molecular characteristics of PC-9 derived erlotinib resistant cell lines.

S. Toyooka, T. Hayashi, Y. Sano, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Development and validation of a symptom illustration scale from the patient-reported outcome common terminology criteria for adverse events for patients with breast cancer

N. Taira, S. Toyooka, T. Shien, 2023, Breast Cancer.

Prolonged warm ischemia exacerbated acute rejection after lung transplantation from donation after cardiac death in a mouse

S. Toyooka, A. Matsukawa, S. Sugimoto, 2019, General Thoracic and Cardiovascular Surgery.

A single nucleotide polymorphism in a gene modulating glucocorticoid sensitivity is associated with the decline in total lung capacity after lung transplantation ST-2018-0396-EO.R1

N. Taira, S. Toyooka, S. Sugimoto, 2019 .

Identification of genetic loci associated with renal dysfunction after lung transplantation using an ethnic-specific single-nucleotide polymorphism array

S. Toyooka, S. Tomida, K. Shien, 2023, Scientific reports.

S. Toyooka, Jun Kato, K. Kuwaki, 2008, Clinical biochemistry.

Best practices for the extraction of genomic DNA from formalin‐fixed paraffin‐embedded tumor tissue for cancer genomic profiling tests

S. Toyooka, S. Tomida, S. Horiguchi, 2021, Pathology international.

What factors determine the survival of patients with an acute exacerbation of interstitial lung disease after lung cancer resection?

S. Toyooka, Y. Sugiyama, H. Date, 2018, Surgery Today.

Randomized phase III study of pemetrexed/cisplatin (Pem/Cis) versus vinorelbine /cisplatin (Vnr/Cis) for completely resected stage II-IIIA non-squamous non-small-cell lung cancer (Ns-NSCLC): The JIPANG study.

S. Toyooka, M. Tsuboi, T. Yamanaka, 2019, Journal of Clinical Oncology.

A Giant Thymic Cyst Accompanied by Acute Mediastinitis.

J. Soh, S. Toyooka, K. Shien, 2020, Acta medica Okayama.

STAT3 expression in activating EGFR-driven adenocarcinoma of the lung.

S. Toyooka, K. Kiura, M. Tanimoto, 2012, Lung cancer.

Pulmonary alveolar proteinosis after lung transplantation: Two case reports and literature review

S. Toyooka, N. Hattori, M. Okazaki, 2023, Respirology case reports.

A Novel Strategy for Treatment of Metastatic Pulmonary Tumors: Radiofrequency Ablation in Conjunction with Surgery

S. Toyooka, H. Date, S. Kanazawa, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Radiofrequency ablation of pulmonary metastases from sarcoma: single-center retrospective evaluation of 46 patients

J. Soh, S. Toyooka, S. Kanazawa, 2017, Japanese Journal of Radiology.

Preoperative cumulative smoking dose on lung cancer surgery in a Japanese nationwide database.

H. Miyata, Kenji Suzuki, S. Toyooka, 2021, The Annals of thoracic surgery.

ASO Author Reflections: Prognostic Impact of the Primary Tumor Resection for Lung Cancer Patients Diagnosed with Pleural Dissemination in the Perioperative Period-Importance of Biomarker-Based Treatment Decision Making.

S. Toyooka, K. Shien, T. Fujiwara, 2023, Annals of surgical oncology.

A PET/CT volumetric parameter predicts prognosis of non-small cell lung cancer treated using preoperative chemoradiotherapy and surgery: A retrospective case series study

S. Toyooka, K. Kiura, M. Kuroda, 2021, Molecular and clinical oncology.

Feasibility of Pulmonary Resection for Lung Cancer in Patients With Coronary Artery Disease or Atrial Fibrillation.

Kenji Suzuki, S. Toyooka, M. Sonobe, 2017, The Annals of thoracic surgery.

Clinical outcome of patients with recurrent non-small cell lung cancer after trimodality therapy

J. Soh, S. Toyooka, S. Miyoshi, 2019, Surgery Today.

The Feasibility of Median Sternotomy With or Without Thoracotomy for Locally Advanced Non-Small Cell Lung Cancer Treated With Induction Chemoradiotherapy.

J. Soh, S. Toyooka, S. Miyoshi, 2016, The Annals of thoracic surgery.

Effect of preoperative long-term use of corticosteroids on the development of post-transplant lymphoproliferative disorders after lung transplantation: a single-center experience in Japan

S. Toyooka, M. Okazaki, S. Sugimoto, 2021, Surgery Today.

EGFR Mutation is a Prognostic Factor in Lung Cancer Patients with Pleural Dissemination Detected During or After Surgery

J. Soh, S. Toyooka, K. Shien, 2023, Annals of Surgical Oncology.

Early effects of the ex vivo evaluation system on graft function after swine lung transplantation.

S. Toyooka, S. Miyoshi, K. Miyoshi, 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Fever after lung radiofrequency ablation: Prospective evaluation of its incidence and associated factors.

J. Soh, S. Toyooka, K. Kiura, 2015, European journal of radiology.

Restrictive allograft dysfunction rather than bronchiolitis obliterans syndrome had a major impact on the overall survival after living-donor lobar lung transplantation.

S. Toyooka, K. Shien, K. Suzawa, 2023, Surgery today.

The impact of prognostic nutrition index on the waitlist mortality of lung transplantation

S. Toyooka, M. Okazaki, S. Sugimoto, 2022, General Thoracic and Cardiovascular Surgery.

Is tumor location an independent prognostic factor in locally advanced non-small cell lung cancer treated with trimodality therapy?

J. Soh, S. Toyooka, S. Miyoshi, 2017, Journal of thoracic disease.

Optimal method for quantitative detection of plasma EGFR T790M mutation using droplet digital PCR system.

J. Soh, S. Toyooka, S. Miyoshi, 2017, Oncology reports.

Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation

S. Toyooka, Shinsuke Hashida, K. Suzawa, 2018, Scientific Reports.

Living-donor lobar lung transplantation for pulmonary arterial hypertension after failure of epoprostenol therapy.

S. Toyooka, M. Aoe, H. Date, 2007, Journal of the American College of Cardiology.